The advent of immune checkpoint inhibitors (ICIs) has revolutionized cancer treatment by harnessing the immune system to target and eliminate cancer cells.
Oct. 22, 2024 — Adults with type 2 diabetes on a low-carbohydrate diet may see benefits to their beta-cell function allowing them to better manage their disease and ... Oct. 17, 2024 ...
AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, ...